DCX and prostate carcinoma: Among prostate cancer patients stratified into high- and low-risk categories, the density of DCX-positive cells exhibits a strong correlation with the aggressiveness of the cancer and the probability of recurrence, thereby highlighting their involvement in initiating neurogenesis and facilitating malignant progression (21).